Tuesday, 02 January 2024 12:17 GMT

Evercare Hospital Ctg's Successful Completion Of First Bone Marrow Transplant


(MENAFN- Bangladesh Monitor)

Dhaka: Evercare Hospital Chattogram announced the successful completion of the first autologous bone marrow transplant (BMT) in the port city. The procedure was performed on a multiple myeloma patient on January 19, 2023, by Dr Abu Jafar Mohammed Saleh and his team.

Dr Saleh and his team are pioneers in the field of BMT in the private sector of Bangladesh, said a press release, adding, they have been providing full-time outpatient and inpatient services along with daycare facilities since January 1, 2023.

Evercare Hospital Chattogram is transforming healthcare in the port city. The hospital has invested in a state-of -the-art Bone Marrow Transplant facility; the first and only one in the region.

BMT is a complex and delicate procedure that involves replacing damaged or destroyed bone marrow with healthy cells. It is a life-saving treatment for patients suffering from blood disorders such as leukemia and lymphoma.

'We are thrilled to announce the successful completion of the first autologous bone marrow transplant in the private sector of Chattogram at Evercare Hospital Chattogram, this is a major milestone for the hospital and the people of Chattogram as well. Now patients no longer must travel to Dhaka or outside of the country for this life-saving treatment,' said Dr Abu Jafar Mohammed Saleh, Senior Consultant and Coordinator, Hematology and BMT Center of Evercare Hospital Chattogram.

'By adding BMT to our services, we are now able to offer patients the best care at a lower cost, making it more accessible for everyone in need,' he further said.

  • T

MENAFN01022023000163011034ID1105506946


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.